Mastaglio, S., Ruggeri, A., Risitano, A. M., Angelillo, P., Yancopoulou, D., Mastellos, D. C., . . . Ciceri, F. (2020). The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol.
Citación estilo ChicagoMastaglio, Sara, et al. "The First Case of COVID-19 Treated With the Complement C3 Inhibitor AMY-101." Clin Immunol 2020.
Cita MLAMastaglio, Sara, et al. "The First Case of COVID-19 Treated With the Complement C3 Inhibitor AMY-101." Clin Immunol 2020.
Precaución: Estas citas no son 100% exactas.